PUMA BIOTECHNOLOGY, INC. — Investor Relations & Filings
Filings indexed
1,055
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
US
United States of America
Listing
US
PBYI
Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. The company's primary commercial product is Nerlynx® (neratinib), an FDA-approved oral medication for certain types of breast cancer. Its clinical pipeline includes alisertib, an investigational drug being evaluated in clinical trials for small cell lung cancer and metastatic breast cancer. The company's mission is to develop and commercialize innovative products to enhance cancer care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-05-07 | English | |
| ARS - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-04-28 | English | |
| SCHEDULE 13G/A - PUMA BIOTECHNOLOGY, INC. (0001401667) (Subject) | 2026-03-27 | English | |
| 10-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-02-26 | English | |
| 8-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-02-26 | English | |
| 4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer) | 2026-02-21 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 43531573 | 8-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-05-07 | English | ||
| 38160772 | ARS - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-04-28 | English | ||
| 33062747 | SCHEDULE 13G/A - PUMA BIOTECHNOLOGY, INC. (0001401667) (Subject) | 2026-03-27 | English | ||
| 32891304 | 10-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-02-26 | English | ||
| 32891296 | 8-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer) | 2026-02-26 | English | ||
| 32700165 | 4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer) | 2026-02-21 | English | ||
| 32700155 | 4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer) | 2026-02-21 | English | ||
| 32700152 | 4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer) | 2026-02-21 | English | ||
| 29414787 | 4 Filing | 2026-01-08 | English | ||
| 29414786 | 4 Filing | 2026-01-08 | English | ||
| 29414770 | 4 Filing | 2026-01-08 | English | ||
|
2025
4 filings
| |||||
| 12162691 | FORM 4 | 2025-11-13 | English | ||
| 12162694 | Regulatory Filings 2025 | 2025-11-12 | English | ||
| 12162697 | FORM 10-Q | 2025-11-06 | English | ||
| 12162702 | FORM 8-K | 2025-11-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
|
Aurinia Pharmaceuticals Inc.
Biopharmaceutical company developing therapies for severe a…
|
AUPH | CA | Manufacturing |
|
Aurisco Pharmaceutical Co.,Ltd.
Develops and manufactures complex APIs and intermediates wi…
|
605116 | CN | Manufacturing |
|
Aurobindo Pharma Ltd.
Vertically integrated developer and manufacturer of generic…
|
AUROPHARMA | IN | Manufacturing |
|
Auro Laboratories Ltd.
Manufactures WHO-GMP compliant APIs and intermediates, spec…
|
530233 | IN | Manufacturing |
|
Aurora Cannabis Inc.
Global producer and distributor of cannabis products for me…
|
ACB | CA | Manufacturing |
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | CA | Manufacturing |
|
AUTOBIO DIAGNOSTICS CO., LTD
Provides IVD solutions for immunoassay, microbiology, and m…
|
603658 | CN | Manufacturing |
|
Autolus Therapeutics plc
Biopharmaceutical company developing programmed T cell ther…
|
AUTL | GB | Manufacturing |
|
AVACTA GROUP PLC
Clinical-stage biotech developing targeted oncology drugs w…
|
AVCT | GB | Manufacturing |
PUMA BIOTECHNOLOGY, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33488/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33488 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33488 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33488 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33488}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PUMA BIOTECHNOLOGY, INC. (id: 33488)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.